乳杆菌气塞菌通过丁酸盐防止与易布鲁替尼相关的心房动
概括
伊布鲁替尼癌症药物通过改变肠道细菌增加了心房动 (AF) 的风险. 恢复Lactobacillus gasseri或丁酸盐通过减少氧化应激和心房重塑来预防AF.
科学领域:
- 心脏病学 心脏病学
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗癌药物易布鲁替尼与心房动 (AF) 风险增加有关.
- 肠道微生物群在药物诱导的AF,特别是易布鲁替尼的作用尚不清楚.
研究的目的:
- 调查肠道微生物群失调是否有助于易布鲁替尼诱导的AF.
- 阐明这种关联背后的机制.
主要方法:
- 16S rRNA 基因测序的基因测序
- 便微生物群移植 便微生物群移植
- 代谢学是指代代谢学.
- 电生理学检查 电生理学检查
- 分子生物学技术分子生物学技术.
主要成果:
- 伊布鲁丁尼布在老鼠中增加了AF敏感性.
- 观察到乳酸菌 (L. gasseri) 的数量减少.
- 用L. gasseri或丁酸盐 (BA) 补充预防了AF.
- 丁酸盐抑制了反应性氧物种的产生和心房重塑.
- 易布鲁替尼破坏了肠道屏障的完整性,抑制了L. gasseri的生长.
结论:
- 肠道微生物群失生症在与易布鲁替尼相关的AF中起作用.
- 针对肠道微生物,如L. gasseri或酸盐,可以防止易布鲁替尼诱导的AF.
- 这项研究为治疗ibrutinib治疗的患者的AF管理开辟了新的治疗途径.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
131
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
131
Drugs for Treatment of Diarrhea-Predominant IBS
145
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
145
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
148
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
148
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
899
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
899
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
707
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
314
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
314


